ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2 | -100.0% | 1,500 | -94.9% | 0.00% | -100.0% |
Q4 2021 | $146,000 | +1522.2% | 29,200 | +3550.0% | 0.01% | – |
Q3 2021 | $9,000 | -43.8% | 800 | -77.8% | 0.00% | -100.0% |
Q2 2021 | $16,000 | -27.3% | 3,600 | +350.0% | 0.00% | 0.0% |
Q1 2021 | $22,000 | -4.3% | 800 | -20.0% | 0.00% | 0.0% |
Q4 2020 | $23,000 | -30.3% | 1,000 | 0.0% | 0.00% | -50.0% |
Q3 2020 | $33,000 | -21.4% | 1,000 | 0.0% | 0.00% | -33.3% |
Q2 2020 | $42,000 | -35.4% | 1,000 | -81.8% | 0.00% | 0.0% |
Q1 2020 | $65,000 | -72.6% | 5,500 | -16.7% | 0.00% | -78.6% |
Q4 2019 | $237,000 | +139.4% | 6,600 | +112.9% | 0.01% | +55.6% |
Q3 2019 | $99,000 | +20.7% | 3,100 | +24.0% | 0.01% | +12.5% |
Q2 2019 | $82,000 | -31.7% | 2,500 | -30.6% | 0.01% | -33.3% |
Q1 2019 | $120,000 | -37.5% | 3,600 | -71.4% | 0.01% | -33.3% |
Q4 2018 | $192,000 | -24.7% | 12,600 | -19.7% | 0.02% | 0.0% |
Q3 2018 | $255,000 | +363.6% | 15,700 | -0.6% | 0.02% | +350.0% |
Q2 2018 | $55,000 | -83.4% | 15,800 | -15.1% | 0.00% | -85.7% |
Q1 2018 | $331,000 | +55.4% | 18,600 | -35.4% | 0.03% | +211.1% |
Q4 2017 | $213,000 | +53.2% | 28,800 | +89.9% | 0.01% | +80.0% |
Q3 2017 | $139,000 | -84.1% | 15,166 | -84.2% | 0.01% | -84.4% |
Q2 2017 | $875,000 | +50.3% | 95,949 | -30.1% | 0.03% | +28.0% |
Q1 2017 | $582,000 | +94.0% | 137,245 | +300.5% | 0.02% | +127.3% |
Q4 2016 | $300,000 | +91.1% | 34,266 | +69.2% | 0.01% | +57.1% |
Q3 2016 | $157,000 | +57.0% | 20,255 | +88.3% | 0.01% | +40.0% |
Q2 2016 | $100,000 | -47.1% | 10,755 | -75.0% | 0.01% | -58.3% |
Q1 2016 | $189,000 | +37.0% | 43,046 | +193.3% | 0.01% | +71.4% |
Q4 2015 | $138,000 | – | 14,678 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 2,679,835 | $99,609,000 | 22.32% |
Bellevue Group AG | 5,465,715 | $203,160,000 | 2.81% |
Rhenman & Partners Asset Management AB | 455,000 | $16,912,000 | 1.50% |
Endurant Capital Management LP | 135,901 | $5,051,000 | 1.49% |
Boxer Capital, LLC | 975,000 | $36,241,000 | 1.25% |
DCF Advisers, LLC | 56,500 | $2,100,000 | 1.07% |
Pentwater Capital Management LP | 2,169,022 | $80,623,000 | 1.04% |
Nicholas Investment Partners, LP | 235,855 | $8,767,000 | 0.95% |
Amia Capital LLP | 20,464 | $761,000 | 0.88% |
HAMILTON LANE ADVISORS LLC | 46,181 | $1,717,000 | 0.83% |